Latest article
New Knowledge on Section 1 Proposed Biosimilar Gan & Lee Insulins Aspart (GL-ASP), Lispro...
BEIJING and BRIDGE WATER, NJ., July 2, 2021 / PRNewswire / - Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan...
How steady glucose screens have remodeled the diabetes panorama
Dexcom G6 applicator
Continuous Glucose Monitors (CGMs) are one of the most powerful diabetes management tools developed over the past few decades.
The FDA approved the...